English
Zydus Lifesciences Q1 Results
- BSE: 532321
- NSE: ZYDUSLIFE
- ISIN: INE010B01027
- Sector: Biotechnology & Drugs
BSE
920.40
-3.95 (-0.43%)
-3.95 (-0.43%)Volume9.11 K
Updated: Tue 9 Dec, 2025 | 14:06:04
NSE
921.40-3.20 (-0.35%)
-3.20 (-0.35%)Volume8.37 L
Updated: Tue 9 Dec, 2025 | 13:51:02
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Zydus Lifesciences Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 25 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 4,780.40 | 4,820.50 | -0.83% | 4,313.60 | 10.82% |
| Depreciation/ Amortization | 238.10 | 237.90 | 0.08% | 215.30 | 10.59% |
| Operating Income | 1,793.30 | 1,707.40 | 5.03% | 1,893.90 | -5.31% |
| Net Income | 1,466.80 | 1,170.90 | 25.27% | 1,419.90 | 3.30% |
| Other Operating Expenses Total | 1,747.60 | 1,694.50 | 3.13% | 1,628.70 | 7.30% |
| Net Income Before Taxes | 1,920.60 | 1,672.00 | 14.87% | 1,899.70 | 1.10% |
| Total Revenue | 6,573.70 | 6,527.90 | 0.70% | 6,207.50 | 5.90% |
| Selling/ General/ Admin Expenses Total | 1,005.20 | 971.40 | 3.48% | 883.50 | 13.77% |
| Diluted Normalized EPS | 14.58 | 13.26 | 9.92% | 14.11 | 3.33% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.